Table 1 Stents distribution in four endpoints included in the analysis
From: Polymer-free dual drug-eluting stents evaluated in a porcine model
14 day | 28 day | 90 day | 191 day | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LAD | LCX | RCA | LAD | LCX | RCA | LAD | LCX | RCA | LAD | LCX | RCA | |
BMS | 7 | 2 | 0 | 3 | 5 | 1 | 5 | 3 | 0 | 4 | 1 | 4 |
PrES | 5 | 5 | 0 | 5 | 4 | 0 | 3 | 4 | 1 | 4 | 5 | 0 |
SES | 2 | 5 | 2 | 5 | 2 | 1 | 3 | 3 | 2 | 5 | 4 | 0 |
DDES | 5 | 4 | 1 | 4 | 4 | 0 | 5 | 3 | 0 | 5 | 1 | 3 |